The world-class Gene Therapy CDMO Partner From Concept to Commercialization
Located on the beautiful campus of UBC Vancouver, Canada, BriGene Biosciences Inc. is dedicated to providing one-stop viral vector-based CDMO services for research and clinical applications.
BriGene has established the integrated innovative biologics CDMO platforms that provide GMP-level plasmid preparation, viral packaging, and T cell production services for large-scale CAR-T productions. In addition, we provide viral vectors, including adenoviral and lentiviral vectors to meet the demands of research and/or manufacturing applications. We are committed to driving innovation and accelerating biologics development from target to market.
With its fermentation capacity ranging from 5L to 500L, uBriGene offers a versatile selection of research grade, GMP-ready or GMP grade plasmids for research and clinical applications respectively. Our two-step purification technology allows for a fast and cost-effective cell harvesting process.
BriGene currently operates two state-of-the-art GMP facilities, including 21 clean suites with a total area of over 133,000 sq ft, and has produced 65 batches of GMP plasmids as of 2021.
Since its founding, BriGene has been providing one-stop service to fulfill comprehensive objectives of our clients, including some of the most cutting-edge leaders of the cell and gene therapy industry. We ensure the highest quality of products and services while striving to optimize time and costs.